Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

219
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
219
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A hybrid piggyBac AAV-transposon and LNP-transposase for treating arginase deficiency: A 100-fold dose reduction compared to AAV alone.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Video inoculation against election misinformation across 12 EU nations.

Communications psychology·2026
Same author

Proteomic Characterization of Major Fish Allergy Responsive Protein Parvalbumins in Hilsa (<i>Tenualosa ilisha</i>): A Commercially Important Fish in Southeast Asia.

Journal of agricultural and food chemistry·2025
Same author

Enrichment of Low-Abundance and Low-Molecular-Weight Proteins in Human Milk Using Mass Spectrometry-Based Proteomics.

ACS omega·2025
Same author

Uncovering the prevalence, key biogenesis enzymes, and biological significance of archaeal lipoproteins.

Nature communications·2025
Same author

Optimised modular anti-FLAG CAR T cells for solid tumor therapy.

Clinical & translational immunology·2025

相关实验视频

Updated: Jan 9, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

752

人工智能如何改变监管提交:当前的临床实施和未来的前景

Jagdeep T Podichetty1, Anna-Marika Bauer1, Rachel Xu1

  • 1Critical Path Institute, Tucson, Arizona, USA.

Clinical and translational science
|December 4, 2025
PubMed
概括

人工智能 (AI) 正在彻底改变药物开发和监管过程. 它通过将基于模型的药物开发与临床实践相结合,提高了效率和患者的结果.

更多相关视频

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.2K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

相关实验视频

Last Updated: Jan 9, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

752
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.2K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 监管科学 监管科学
  • 计算机科学 计算机科学

背景情况:

  • 人工智能 (AI) 越来越多地被纳入制药研究和开发.
  • 传统的药物开发途径在效率和精度方面面临挑战.
  • 数据分析和监管科学的融合需要先进的工具.

研究的目的:

  • 探索人工智能对药物开发和监管提交的变革性影响.
  • 突出人工智能的作用,将基于模型的药物开发 (MIDD) 与临床实施相结合.
  • 讨论当前的应用,监管整合以及人工智能在制药领域的未来前景.

主要方法:

  • 审查当前AI应用在药物发现和开发中的应用.
  • 对人工智能融入监管框架的分析.
  • 关于人工智能在以患者为中心的药物开发中的未来趋势和潜力的观点.

主要成果:

  • 人工智能能够实现先进的数据分析,预测建模和智能决策支持.
  • 人工智能促进了MIDD和临床实践之间的翻译桥梁.
  • 人工智能提高了治疗精度,并通过数据驱动的见解改善了患者的治疗结果.

结论:

  • 人工智能是加速高效,数据驱动和以患者为中心的药物开发的关键驱动力.
  • 监管机构越来越多地考虑人工智能驱动的证据.
  • 药物开发的未来将在很大程度上受到人工智能进步的影响.